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INTRODUCTION
Concurrent intracranial lesions can be accidentally 
detected by preoperative radiologic evaluation in patients 
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Objective: Few studies have investigated treatment strategies for brain tumor with a coexisting unruptured intracranial 
aneurysm (cUIA). The purpose of this study was to evaluate the safety and efficacy of preoperative coiling for cUIA, and 
subsequent brain tumor surgery.
Materials and Methods: A total of 19 patients (mean age, 55.2 years; M:F = 4:15) underwent preoperative coiling for 23 
cUIAs and subsequent brain tumor surgery. Primary brain tumors were meningiomas (n = 7, 36.8%), pituitary adenomas (n 
= 7, 36.8%), gliomas (n = 3, 15.8%), vestibular schwannoma (n = 1, 5.3%), and Rathke’s cleft cyst (n = 1, 5.3%). cUIAs 
were located at the distal internal carotid artery (n = 9, 39.1%), anterior cerebral artery (n = 8, 34.8%), middle cerebral 
artery (n = 4, 17.4%), basilar artery top (n = 1, 4.3%), and posterior cerebral artery, P1 segment (n = 1, 4.3%). The 
outcomes of preoperative coiling of cUIA and subsequent brain tumor surgery were retrospectively evaluated. 
Results: Single-microcatheter technique was used in 13 cases (56.5%), balloon-assisted in 4 cases (17.4%), double-
microcatheter in 4 cases (17.4%), and stent-assisted in 2 cases (8.7%). Complete cUIA occlusion was achieved in 18 cases 
(78.3%), while residual neck occurred in 5 cases (21.7%). The only coiling-related complication was 1 transient ischemic 
attack (5.3%). Neurological deterioration did not occur in any patient during the period between coiling and tumor surgery. 
At the latest clinical follow-up (mean, 29 months; range, 2–120 months), 15 patients (78.9%) had favorable outcomes 
(modified Rankin Scale, 0–2), while 4 patients (21.1%) had unfavorable outcomes due to consequences of brain tumor 
surgery.
Conclusion: Preoperative coiling and subsequent tumor surgery was safe and effective, making it a reasonable treatment 
option for patients with brain tumor and cUIA. 
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with a brain tumor. Coexistent lesions are a new clinical 
concern to neurosurgeons. Cases of coexisting unruptured 
intracranial aneurysm (cUIA) are particularly worrying 
to neurosurgeons since cUIA rupture can be fatal during 
the perioperative period (1, 2). Previous studies reported 
that the incidence of cUIA associated with brain tumor 
ranged from 2.3% to 7.7% (3-9). Considering the variable 
incidence of cUIA associated with brain tumors (3-9), 
there are a considerable number of cases in literature 
documenting perioperative aneurysm rupture (10-14). This 
data emphasizes the importance of cUIA management 
before tumor treatment (1, 2, 10-14). However, few studies 
have investigated treatment strategies for brain tumor with 
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carotid or vertebral artery. A bolus of 3000 IU heparin was 
administered intravenously, and maintained with a dose 
of 1000 IU/hour. If stent-assist coiling was planned, dual 
anti-platelet agents were prescribed to the patient for 
at least 5 days before the procedure. Dual anti-platelet 
medication was maintained for 3 months post-operation, 
and then changed to aspirin monotherapy for patients with 
stent-assisted coiling. Coiling technique and angiographic 
outcomes were retrospectively evaluated. Angiographic 
outcome was determined by Raymond’s classification. 
Variables
Procedure-related complications, defined as any clinical 
deterioration (either transient or permanent) after 
treatment, were evaluated by immediate postprocedural 
imaging studies, electronic medical records, and a 
neurointerventional database. Clinical outcomes were 
determined at the latest clinical follow-up on an outpatient 
basis, or by telephone interview according to the modified 
Rankin Scale (mRS). Favorable outcomes were defined as 
mRS 0–2. 
RESULTS
Nineteen patients (15 female) underwent preoperative 
coiling for 23 cUIA and subsequent brain tumor surgery. The 
mean age was 55.2 years, ranging from 33 to 73 years. 
Primary tumors were meningiomas (n = 7, 36.8%), 
pituitary adenomas (n = 7, 36.8%), gliomas (n = 3, 15.8%), 
vestibular schwannoma (n = 1, 5.3%), and Rathke’s cleft 
cyst (n = 1, 5.3%). cUIAs were located at the distal internal 
carotid artery (n = 9, 39.1%), anterior cerebral artery (n = 8, 
34.8%), middle cerebral artery (n = 4, 17.4%), basilar artery 
top (n = 1, 4.3%), and posterior cerebral artery P1 (n = 1, 
4.3%). The characteristics of these patients are summarized 
in Table 1. 
The single-microcatheter technique was used in 13 cases 
(56.5%), balloon-assisted was used in 4 cases (17.4%), 
double-microcatheter was used in 4 cases (17.4%), and 
stent-assisted was used in 2 cases (8.7%). Complete cUIA 
occlusion was achieved in 18 cases (78.3%), while residual 
neck occurred in 5 cases (21.7%). No technical failures were 
noted. Follow-up MR or catheter angiogram was performed 
in 15 patients (78.9%) with 18 cUIA at 6 months or more 
(mean 25 months). There were 14 cases (77.8%) of “stable”, 
2 cases (11.1%) of “minor recurrence”, and 2 cases (11.1%) 
of “major recurrence”, respectively. One of the “major 
cUIA (15-19). Preoperative coiling and subsequent tumor 
surgery is one strategic option for treating cUIA prior to 
brain tumor surgery. However, few cases exist in literature, 
which were treated by this strategy (17-19).
The purpose of our study is to evaluate the safety 
and effectiveness of preoperative coiling for cUIA and 
subsequent brain tumor surgery, in patients with brain 
tumor and cUIA.
 
MATERIALS AND METHODS
This retrospective study was approved by the institutional 
review board and informed patient consent was waived for 
study inclusion based on study characteristics. Radiologic 
and clinical data were recorded in a prospectively 
maintained neurointerventional database, and were 
retrospectively reviewed.
Between November 2003 and November 2014, the 
patients who underwent preoperative coiling for cUIA 
and subsequent brain tumor surgery were identified from 
a prospectively maintained neurointerventional database 
of a single tertiary referral academic hospital. All patients 
were clinically assessed at the time of admission and at 
post-treatment (coiling and brain tumor surgery). Clinical 
outcomes were evaluated at the latest clinical follow-
up on an outpatient basis or by telephone interview. All 
cUIAs were identified during preoperative evaluation of 
the known brain tumor. Each case was discussed by the 
neurointerventionists and neurosurgeons for determining 
the treatment strategy. Coiling prior to tumor surgery 
was considered based on at least one of the following 
conditions: 1) aneurysm with maximal size ≥ 5 mm, which 
is an internal criteria of the study hospital for preoperative 
coiling, 2) neighboring aneurysm near the tumor, which 
potentially compromise tumor surgery, 3) expected unstable 
hemodynamic situation during the perioperative period 
(highly vascular tumor or sinus invasion by tumor), or 
4) demand by the oncologic neurosurgeon, based on 
the operative plan. Informed consent for treatment was 
obtained from the patient or legal representatives. 
Endovascular Treatment
All coiling procedures were performed under general 
anesthesia (n = 18) or intravenous sedation (n = 1). After 
femoral access, a 6-Fr Envoy (Cordis, Miami Lakes, FL, 
USA) guiding catheter or shuttle guiding sheath (Cook, 
Bloomington, IN, USA) was introduced into the internal 
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recurrence” was successfully re-treated by additional simple 
coiling.
Clinical outcomes after preoperative cUIA coiling and 
tumor surgery are summarized in the Table 1. Transient 
ischemic attack (grade 4 contralateral hemiparesis) occurred 
after coiling in 1 patient. This was the only case of coiling-
related complications (5.3%). At mean follow-up of 29 
months, 15 patients (78.9%) had favorable outcomes 
(mRS, 0–2). There was 1 case (5.3%) of coiling-related 
complication and 4 cases (21.1%) of tumor surgery-related 
complications.
The median interval between coiling and tumor 
surgery was 55 days (range, 2–211 days). Neurological 
deterioration was not observed in any patient during the 
Fig. 1. 53-year-old woman presenting with pituitary adenoma and coexisting unruptured aneurysm.
A. Coronal view of T2 weighted MRI shows 5.3-mm sized aneurysm (arrow) buried in PA. Arrowheads indicate right internal carotid artery. B. 
Oblique coronal view of flat panel angiographic CT shows small aneurysm (arrow) arising from right internal carotid artery, with dome buried in 
PA. C. Control angiogram after coiling shows complete aneurysm occlusion. D. 6-month follow-up MR angiogram shows complete occlusion state 
of aneurysm (white arrow). PA = pituitary adenoma
A
C
B
D
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period between coiling and tumor surgery. Tumor surgery-
related complications occurred in 4 patients (21.1%): 
hydrocephalus (n = 1), hemorrhage (n = 1), subdural 
hematoma infection (n = 1), and motor weakness due to 
brain edema after removal of a large meningioma (n = 1). 
In these patients, aneurysms were treated by simple coiling 
Fig. 2. 55-year-old man presenting with high grade glioma and concurrent unruptured aneurysm.
A. Axial view of T2 weighted MRI shows 7.7-mm sized aneurysm (arrow) at anterior communicating artery and brain tumor with cystic portion (T) 
in left frontotemporal region. Note dome of aneurysm is toward brain tumor. B. Working projection view of angiogram during coiling. C. Control 
angiogram after coiling shows complete occlusion of aneurysm. D. Axial view of T2 weighted MRI after tumor surgery. Arrow indicated coiled 
aneurysm.
A
C
B
D
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(n = 3) or balloon-assisted coiling (n = 1). No anti-platelet 
agents were administered after coiling. Clinical follow-
up was achieved in 19 patients, with a mean follow-up 
period of 29 months after the final treatment (range, 2–120 
months). Favorable outcomes were observed in 15 patients 
(78.9%). Among them, initial functional status of 2 patients 
(#17 and #18) was mRS 2 due to hemiparesis by malignant 
brain tumor, and did not changed after coiling and tumor 
surgery. Meanwhile, 4 patients (21.1%) had unfavorable 
outcomes at the latest follow-up. Causes of unfavorable 
outcomes were ischemic stroke after radiation therapy (n = 
1), recurrence and multiple metastasis of underlying renal 
Fig. 3. 68-year-old woman presenting with left parietal convexity meningioma and coexisting unruptured aneurysm.
A. Sagittal view of enhanced MR shows meningioma with peritumoral edema in left parietal convexity. B. Lateral projection of left internal 
carotid angiogram shows large aneurysm with daughter sac at left posterior communicating artery origin. C. Control angiogram after coiling 
shows complete aneurysm occlusion. D. MR-DWI obtained due to transient ischemic attack (grade 4 contralateral hemiparesis) shows several high 
signal spots. MR-DWI = magnetic resonance diffusion weighted imaging
A
C
B
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cell carcinoma (n = 1), weakness after brain tumor surgery (n 
= 1), and sepsis (n = 1) from subdural hematoma infection 
(Table 1).
DISCUSSION 
The overall outcomes of patients after treatment of both 
cUIAs and tumors were favorable in 78.9% of patients 
and unfavorable in 21.1% of patients during a mean of 29 
months (range, 2–120 months) follow-up. No patient had 
any neurological deterioration during the period between 
coiling and tumor surgery. All unfavorable outcomes 
were related to brain tumor-related complications, 
tumor progression, or underlying malignancy (renal cell 
carcinoma).
With the recent development of neuroimaging techniques, 
cUIAs have been increasingly detected along with primary 
brain tumors. In this study, since all brain tumor patients 
were not evaluated with vascular imaging (MR/CT or 
catheter angiogram) due to its retrospective nature, the 
overall incidence of cUIA with brain tumor could not be 
analyzed. Previous studies reported that the incidence of 
cUIA associated with brain tumor ranges from 2.3% to 7.0%, 
and the most common combination was a meningioma (3-9). 
Treatment strategies for brain tumor and cUIA have not 
yet been established. Because the tumor is responsible for 
presenting symptoms in most cases, treatment strategies 
should focus on tumor surgery (16). If a cUIA is small and 
distantly located from the brain tumor, tumor surgery can 
be performed first and the cUIA can be followed up or 
treated later. However, depending on the cUIA location and 
size, the cUIA should be treated prior to tumor surgery. For 
cUIAs adjacent to brain tumors (Figs. 1, 2), the aneurysm 
should be treated prior to tumor surgery because the 
aneurysm may be inadvertently injured and rupture during 
or after tumor surgery (10-15). The risk of rupturing a 
cUIA, especially a large one (Fig. 3), may increase due 
to hemodynamic changes during or after tumor removal. 
We had one case of aneurysm rupture shortly after tumor 
surgery (unpublished data). 
Several strategic options exist when an untreated cUIA 
poses a threat during or after tumor surgery. Simultaneous 
aneurysm clipping and tumor removal is occasionally 
possible, depending on the anatomical relationship 
between the tumor and cUIA (15). In general, this strategy 
is technically more demanding, and may increase the 
possibility of complications during or after tumor surgery. 
Another option is a staged operation to clip the cUIA 
Fig. 3. 68-year-old woman presenting with left parietal convexity meningioma and coexisting unruptured aneurysm.
E. Axial view of T2 weighted MRI after tumor removal. Patient had grade 4 contralateral weakness after brain tumor surgery, but recovered over 
several weeks. F. 2-year follow-up MR angiogram shows complete occlusion state of aneurysm (white arrow). 2-year Functional status of this 
patient was mRS 1. mRS = modified Rankin Scale
E F
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with subsequent tumor surgery. However, this involves 
repeat craniotomy and delays tumor surgery, more than the 
preoperative coiling strategy. Endovascular treatment of 
UIA is very safe and effective even in wide neck and large 
aneurysms (20-23). Thus, cUIA coiling and subsequent 
tumor surgery is an alternative option. However, only a few 
cases treated by this strategy are reported in literature (17-
19). To our knowledge, this study is the first case series 
collected over an 11-year period at a single large center, 
where the safety and efficacy of preoperative coiling and 
subsequent brain tumor surgery has been evaluated. 
This strategy has several advantages. First, it eliminates 
the concern of possible severe complications associated 
with cUIA during tumor surgery. It is a more simplified 
tumor surgery than the one stage operation of cUIA and 
brain tumor. Second, this technique alleviates the burden of 
repeat craniotomy. Finally, delay time for tumor surgery is 
lesser than the strategy of clipping and subsequent tumor 
surgery. One major concern about preoperative coiling is 
the use of antiplatelet medication with stents. In our study, 
only 2 aneurysms (8.7%) were treated with stent-assisted 
coiling due to wide neck (dome to neck ratio ≤ 1.5) and 
under-tall (aspect ratio ≤ 1.0) aneurysm. These patients 
had slowly growing benign tumors without urgent clinical 
symptoms, and a delay in tumor surgery did not matter. 
Another major concern is that periprocedural complications 
of coiling might delay tumor operations. In general, 
however, the morbidity of coiling for cUIA is very low. In 
our series, there was only 1 transient ischemic attack, which 
neither delayed tumor surgery nor affected the clinical 
outcome.
This study has several limitations. First, due to its 
retrospective nature, interval between coiling and tumor 
surgery was very variable (2–211 days), and indication for 
preoperative coiling of cUIA was not strict. In 2 patients 
with stent-assisted coiling, antiplatelet medication delayed 
tumor surgery. Meanwhile, in the other patients, surgery was 
delayed due to a slow growing benign tumor, preoperative 
medical treatment, and elective operation schedule. 
Secondly, a small number of cases in this study may limit 
the generalizability of study results. However, prevalence 
of cUIA with brain tumor is very low, the effectiveness and 
safety of preoperative coiling for cUIA were focused in this 
study. 
In cases of cUIA and brain tumor, treatment strategies 
should be designed according to the tumor and aneurysm 
conditions, locations, and pathologic nature. Preoperative 
cUIA coiling generally has low morbidity, can simplify 
tumor surgery, and results in fewer tumor surgery delays 
than the strategy of staged clipping with subsequent tumor 
surgery. If cUIA treatment is needed prior to tumor surgery, 
preoperative cUIA coiling with subsequent tumor surgery is 
a good treatment option. 
In conclusion, Preoperative coiling with subsequent 
tumor surgery was safe and effective. It is a reasonable 
treatment option for patients with concurrent brain tumor 
and cUIA.
REFERENCES
1. Tsuchida T, Tanaka R, Yokoyama M, Sato H. Rupture 
of anterior communicating artery aneurysm during 
transsphenoidal surgery for pituitary adenoma. Surg Neurol 
1983;20:67-70
2. Taylor PE. Delayed postoperative hemorrhage from 
intracranial aneurysm after craniotomy for tumor. Neurology 
1961;11:225-231
3. Javalkar V, Guthikonda B, Vannemreddy P, Nanda A. 
Association of meningioma and intracranial aneurysm: 
report of five cases and review of literature. Neurol India 
2009;57:772-776
4. Oh MC, Kim EH, Kim SH. Coexistence of intracranial aneurysm 
in 800 patients with surgically confirmed pituitary adenoma. 
J Neurosurg 2012;116:942-947
5. Oshino S, Nishino A, Suzuki T, Arita H, Tateishi A, Matsumoto 
K, et al. Prevalence of cerebral aneurysm in patients with 
acromegaly. Pituitary 2013;16:195-201
6. Pant B, Arita K, Kurisu K, Tominaga A, Eguchi K, Uozumi T. 
Incidence of intracranial aneurysm associated with pituitary 
adenoma. Neurosurg Rev 1997;20:13-17
7. Fischer BR, Palkovic S, Holling M, Niederstadt T, Jeibmann 
A, Wassmann H. Coexistence of cerebral aneurysm and 
meningioma--pure accident?. Clin Neurol Neurosurg 
2009;111:647-654
8. Jakubowski J, Kendall B. Coincidental aneurysms with 
tumours of pituitary origin. J Neurol Neurosurg Psychiatry 
1978;41:972-979
9. Kim YH, Lee YJ, Han JH, Ahn S, Lee J, Kim JH, et al. 
Association of intracranial aneurysms and meningiomas: a 
case-control study. J Neurosurg 2015;123:357-361
10. Akutsu N, Hosoda K, Ohta K, Tanaka H, Taniguchi M, 
Kohmura E. Subarachnoid hemorrhage due to rupture of an 
intracavernous carotid artery aneurysm coexisting with a 
prolactinoma under cabergoline treatment. J Neurol Surg Rep 
2014;75:e73-e76
11. Cheng WY, Shen CC. Minimally invasive approaches to 
treat simultaneous occurrence of glioblastoma multiforme 
and intracranial aneurysm -- case report. Minim Invasive 
Neurosurg 2004;47:181-185
12. Hoya K, Yoshimoto Y, Shin M, Nemoto S. Rupture of 
939
Preoperative Coiling of Coexisting Aneurysm with Brain Tumor
Korean J Radiol 17(6), Nov/Dec 2016kjronline.org
an internal carotid artery aneurysm within a clinoidal 
meningioma following stereotactic radiosurgery. Acta 
Neurochir (Wien) 2011;153:1995-1996
13. Rustagi T, Uy EM, Rai M, Kannan S, Senatus P. Intracranial 
hemorrhage from undetected aneurysmal rupture 
complicating transphenoidal pituitary adenoma resection. 
Conn Med 2011;75:393-398
14. Berker M, Aghayev K, Saatci I, Palaog˘lu S, Onerci M. 
Overview of vascular complications of pituitary surgery 
with special emphasis on unexpected abnormality. Pituitary 
2010;13:160-167
15. Zhong Z, Sun Y, Lin D, Sun Q, Bian L. Surgical treatment of 
brain tumor coexisted with intracranial aneurysm--case series 
and review of the literature. Neurosurg Rev 2013;36:645-656; 
discussion 656
16. Licata C, Pasqualin A, Freschini A, Barone G, Da Pian R. 
Management of associated primary cerebral neoplasms and 
vascular malformations: 1. intracranial aneurysms. Acta 
Neurochir (Wien) 1986;82:28-38
17. Yamada S, Yamada SM, Hirohata T, Ishii Y, Hoya K, Murakami 
M, et al. Endoscopic extracapsular removal of pituitary 
adenoma: the importance of pretreatment of an adjacent 
unruptured internal carotid artery aneurysm. Case Rep Neurol 
Med 2012;2012:891847
18. Xia X, Ramanathan M, Orr BA, Salmasi V, Salvatori R, Reh DD, 
et al. Expanded endonasal endoscopic approach for resection 
of a growth hormone-secreting pituitary macroadenoma 
coexistent with a cavernous carotid artery aneurysm. J Clin 
Neurosci 2012;19:1437-1441
19. Yu K, Herwadkar A, Kearney T, Gnanalingham KK. Pituitary 
adenoma and incidental superior hypophyseal aneurysm. Br J 
Neurosurg 2011;25:432-433
20. Cho YD, Rhim JK, Kang HS, Park JJ, Jeon JP, Kim JE, et 
al. Use of triple microcatheters for endovascular treatment 
of wide-necked intracranial aneurysms: a single center 
experience. Korean J Radiol 2015;16:1109-1118
21. Cho YD, Rhim JK, Park JJ, Jeon JS, Yoo RE, Kang HS, et al. 
Microcatheter looping to facilitate aneurysm selection in 
coil embolization of paraclinoid aneurysms. Korean J Radiol 
2015;16:899-905
22. Kim BM, Shin YS, Baik MW, Lee DH, Jeon P, Baik SK, et al. 
Pipeline embolization device for large/giant or fusiform 
aneurysms: an initial multi-center experience in Korea. 
Neurointervention 2016;11:10-17
23. Kwon WH, Jeong HW, Kim ST, Seo JH. Angiographic and 
clinical result of endovascular treatment in paraclinoid 
aneurysms. Neurointervention 2014;9:83-88    
